Cheil Bio Co

Cheil Bio Co Earnings Yield

Delisted·Feb 25, 2026

The Earnings Yield of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is -6.70 %. In the previous year, Earnings Yield was -23.27 % — a change of -71.19% (higher).

Earnings Yield

-6.70 %

YoY

-71.19%

Last updated:

Earnings Yield of Cheil Bio Co is 2024 -6.70 % . Earnings Yield of Cheil Bio Co was 2023 -23.27 % . It decreases by -71.19% higher compared to the previous year.

The Cheil Bio Co Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2017
12.70 KRW
Jan 1, 2018
16.74 KRW
Jan 1, 2019
32.88 KRW
Jan 1, 2020
15.99 KRW
Jan 1, 2021
-11.46 KRW
Jan 1, 2022
-27.48 KRW
Jan 1, 2023
-23.27 KRW
Jan 1, 2024
-6.70 KRW
The Cheil Bio Co Earnings Yield history
YEAREarnings YieldYoY
-6.70 %-71.19%
-23.27 %-15.34%
-27.48 %+139.73%
-11.46 %-171.68%
15.99 %-51.35%
32.88 %+96.40%
16.74 %+31.80%
12.70 %-22.17%
16.32 %+19.05%
13.71 %-10.89%
15.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Earnings Yield of Cheil Bio Co is -6.70 % in 2024.

Earnings Yield of Cheil Bio Co changed from -23.27 % to -6.70 %, representing a -71.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cheil Bio Co

All Key Metrics — Cheil Bio Co